These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32987358)

  • 21. Extrastriatal
    Nicastro N; Garibotto V; Burkhard PR
    BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes.
    Knudsen K; Fedorova TD; Horsager J; Andersen KB; Skjærbæk C; Berg D; Schaeffer E; Brooks DJ; Pavese N; Van Den Berge N; Borghammer P
    J Parkinsons Dis; 2021; 11(4):1677-1687. PubMed ID: 34334424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
    J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.
    Eisensehr I; Linke R; Noachtar S; Schwarz J; Gildehaus FJ; Tatsch K
    Brain; 2000 Jun; 123 ( Pt 6)():1155-60. PubMed ID: 10825354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VMAT2 availability in Parkinson's disease with probable REM sleep behaviour disorder.
    Valli M; Cho SS; Uribe C; Masellis M; Chen R; Mihaescu A; Strafella AP
    Mol Brain; 2021 Nov; 14(1):165. PubMed ID: 34758845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.
    Yousaf T; Pagano G; Niccolini F; Politis M
    J Neurol Sci; 2018 Apr; 387():220-227. PubMed ID: 29571867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of early caudate dysfunction in Parkinson's disease.
    Pasquini J; Durcan R; Wiblin L; Gersel Stokholm M; Rochester L; Brooks DJ; Burn D; Pavese N
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1098-1104. PubMed ID: 31079063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD.
    Arnaldi D; Morbelli S; Brugnolo A; Girtler N; Picco A; Ferrara M; Accardo J; Buschiazzo A; de Carli F; Pagani M; Nobili F
    Parkinsonism Relat Disord; 2016 Aug; 29():47-53. PubMed ID: 27264343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years.
    Chouker M; Tatsch K; Linke R; Pogarell O; Hahn K; Schwarz J
    Nucl Med Commun; 2001 Jun; 22(6):721-5. PubMed ID: 11403185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort.
    Kim R; Lee J; Kim Y; Kim A; Jang M; Kim HJ; Jeon B; Kang UJ; Fahn S
    Parkinsonism Relat Disord; 2018 Jun; 51():49-54. PubMed ID: 29523394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
    Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
    J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline.
    Barber TR; Griffanti L; Bradley KM; McGowan DR; Lo C; Mackay CE; Hu MT; Klein JC
    Ann Clin Transl Neurol; 2020 Jan; 7(1):26-35. PubMed ID: 31820587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
    Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
    Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease.
    Kaasinen V; Kinos M; Joutsa J; Seppänen M; Noponen T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1931-7. PubMed ID: 24867256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.